Press releases
-
-
-
Internal link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
-
-
-
-
-
-
-
-
-
Internal link ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
-
-
-
Internal link Lilly and ProQR to Expand RNA Editing Collaboration
-
-
-
Internal link ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
-
Internal link ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs
-
-
-
Internal link ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates
-
-
-